Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Comments
Loading...
IO Biotech Analyst Ratings and Price Targets | NASDAQ:IOBT | Benzinga
IO Biotech Inc has a consensus price target of $9.33 based on the ratings of 3 analysts. The high is $12 issued by HC Wainwright & Co. on March 5, 2025. The low is $6 issued by Morgan Stanley on September 16, 2024. The 3 most-recent analyst ratings were released by HC Wainwright & Co. on March 5, 2025, November 12, 2024, and November 6, 2024, respectively. With an average price target of $12 between HC Wainwright & Co., there's an implied 948.03% upside for IO Biotech Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
HC Wainwright & Co.
Morgan Stanley
Piper Sandler
1calculated from analyst ratings
Analyst Ratings for IO Biotech
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 03/05/2025 | Buy Now | 948.03% | HC Wainwright & Co. | Emily Bodnar39% | $12 → $12 | Reiterates | Buy → Buy | Get Alert |
| 11/12/2024 | Buy Now | 948.03% | HC Wainwright & Co. | Emily Bodnar39% | $12 → $12 | Reiterates | Buy → Buy | Get Alert |
| 11/06/2024 | Buy Now | 948.03% | HC Wainwright & Co. | Emily Bodnar39% | $12 → $12 | Reiterates | Buy → Buy | Get Alert |
| 09/16/2024 | Buy Now | 424.02% | Morgan Stanley | Matthew Harrison60% | $4 → $6 | Maintains | Overweight | Get Alert |
| 09/16/2024 | Buy Now | 948.03% | HC Wainwright & Co. | Emily Bodnar39% | $12 → $12 | Reiterates | Buy → Buy | Get Alert |
| 09/03/2024 | Buy Now | 773.36% | Piper Sandler | Christopher Raymond57% | $10 → $10 | Maintains | Overweight | Get Alert |
| 09/03/2024 | Buy Now | 249.34% | Morgan Stanley | Matthew Harrison60% | $7 → $4 | Maintains | Overweight | Get Alert |
| 09/03/2024 | Buy Now | 948.03% | HC Wainwright & Co. | Emily Bodnar39% | $12 → $12 | Reiterates | Buy → Buy | Get Alert |
| 08/14/2024 | Buy Now | 948.03% | HC Wainwright & Co. | Emily Bodnar39% | $12 → $12 | Reiterates | Buy → Buy | Get Alert |
| 05/15/2024 | Buy Now | 948.03% | HC Wainwright & Co. | Emily Bodnar39% | $8 → $12 | Maintains | Buy | Get Alert |
| 03/06/2024 | Buy Now | 598.69% | HC Wainwright & Co. | Emily Bodnar39% | $8 → $8 | Reiterates | Buy → Buy | Get Alert |
| 09/28/2023 | Buy Now | 773.36% | Piper Sandler | Christopher Raymond57% | → $10 | Initiates | → Overweight | Get Alert |
| 09/13/2023 | Buy Now | 598.69% | HC Wainwright & Co. | Emily Bodnar39% | → $8 | Reiterates | Buy → Buy | Get Alert |
| 08/15/2023 | Buy Now | 511.35% | Morgan Stanley | Matthew Harrison60% | $11 → $7 | Maintains | Overweight | Get Alert |
| 08/11/2023 | Buy Now | 598.69% | HC Wainwright & Co. | Emily Bodnar39% | $11 → $8 | Reiterates | Buy → Buy | Get Alert |
| 03/15/2023 | Buy Now | 773.36% | HC Wainwright & Co. | Emily Bodnar39% | → $10 | Reiterates | → Buy | Get Alert |
| 01/24/2023 | Buy Now | 860.7% | Morgan Stanley | Matthew Harrison60% | $15 → $11 | Maintains | Overweight | Get Alert |
| 11/21/2022 | Buy Now | 773.36% | HC Wainwright & Co. | Emily Bodnar39% | → $10 | Initiates | → Buy | Get Alert |
FAQ
What is the target price for IO Biotech (IOBT) stock?
The latest price target for IO Biotech (NASDAQ:IOBT) was reported by HC Wainwright & Co. on March 5, 2025. The analyst firm set a price target for $12.00 expecting IOBT to rise to within 12 months (a possible 948.03% upside). 10 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for IO Biotech (IOBT)?
The latest analyst rating for IO Biotech (NASDAQ:IOBT) was provided by HC Wainwright & Co., and IO Biotech reiterated their buy rating.
When was the last upgrade for IO Biotech (IOBT)?
There is no last upgrade for IO Biotech
When was the last downgrade for IO Biotech (IOBT)?
There is no last downgrade for IO Biotech.
When is the next analyst rating going to be posted or updated for IO Biotech (IOBT)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of IO Biotech, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for IO Biotech was filed on March 5, 2025 so you should expect the next rating to be made available sometime around March 5, 2026.
Is the Analyst Rating IO Biotech (IOBT) correct?
While ratings are subjective and will change, the latest IO Biotech (IOBT) rating was a reiterated with a price target of $12.00 to $12.00. The current price IO Biotech (IOBT) is trading at is $1.15, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.